Lexaria Bioscience (CSE: LXX- Nasdaq: LEXXW) CEO Chris Bunka joined Steve Darling from Proactive to share news the company has released positive results from its extended stability testing for bottled CBD-containing beverages prepared using its technology.
Bunka telling Proactive Lexaria’s DehydraTECH CBD nanoemulsification formulation and processing techniques tested in beverages maintained their CBD content which was verified at 93.4% of target potency one year after production and also evidenced excellent microbial purity over this period.